Home » Authors » James Etheridge

Articles by James Etheridge

GenOway Signs 2 Agreements to Provide Mouse-Rat Lines

April 9, 2008

By James Etheridge

BioAlliance, Handok Team for Loramyc Distribution

April 2, 2008

By James Etheridge

Mapreg Gets Orphan Status for Spinal Cord Injury Drug

March 26, 2008

By James Etheridge

Cellectis in Suit with Precision for Patent Infringement

March 19, 2008

By James Etheridge

TxCell Completes €10.5M Round and Begins First Clinical Trial

March 12, 2008

By James Etheridge

No Abstract

Trophos Gets $1.4M Grant to Validate Drug in IRI

March 5, 2008

By James Etheridge

NicOx Begins Osteo Trials of Anti-Inflammatory Naproxcinod

March 5, 2008

By James Etheridge

NicOx Begins Osteo Trials of Anti-Inflammatory Naproxcinod

March 5, 2008

By James Etheridge

Trophos Gets $1.4M Grant to Validate Drug in IRI

March 5, 2008

By James Etheridge

Immtech Drops Pafuramidine Due to Liver Safety Concerns

Feb. 27, 2008

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...